I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| CD4-positive, alpha-beta T cell | 6 studies | 23% ± 6% | |
| epithelial cell | 5 studies | 33% ± 17% | |
| fibroblast | 5 studies | 23% ± 9% | |
| basal cell | 5 studies | 24% ± 12% | |
| regulatory T cell | 5 studies | 21% ± 2% | |
| B cell | 4 studies | 19% ± 5% | |
| endothelial cell | 4 studies | 29% ± 7% | |
| CD8-positive, alpha-beta T cell | 4 studies | 25% ± 6% | |
| hematopoietic precursor cell | 3 studies | 31% ± 9% | |
| conventional dendritic cell | 3 studies | 28% ± 10% | |
| naive thymus-derived CD4-positive, alpha-beta T cell | 3 studies | 17% ± 1% | |
| naive thymus-derived CD8-positive, alpha-beta T cell | 3 studies | 22% ± 2% | |
| connective tissue cell | 3 studies | 19% ± 2% | |
| natural killer cell | 3 studies | 25% ± 4% | |
| ciliated cell | 3 studies | 20% ± 4% | |
| abnormal cell | 3 studies | 21% ± 3% | |
| endothelial cell of vascular tree | 3 studies | 18% ± 3% | |
| dendritic cell | 3 studies | 33% ± 10% | |
| intestinal crypt stem cell | 3 studies | 27% ± 7% | |
| hematopoietic stem cell | 3 studies | 23% ± 4% | |
| CD4-positive, alpha-beta memory T cell | 3 studies | 19% ± 1% |
